




 |
  |
| |
|
| |
Loss
of Cell-Cell Contact Is Induced by Integrin-Mediated Cell-Substratum Adhesion
in Highly Motile and Highly Metastatic Hepatocellular Carcinoma Cells |














|
|
Takuya Genda, Michiie Sakamoto, Takafumi Ichida, Hitoshi Asakura, and
Setsuo Hirohashi
|
| |
|
| |
Pathology
Division (TG, MS, SH), National Cancer Center Research Institute, Tokyo;
and The Third Department of Internal Medicine (TG, TI, HA), Faculty of Medicine,
Niigata University, Niigata, Japan |
| |
|
| |
SUMMARY: The cadherin-mediated cell-cell adhesion system plays a critical
role in normal development and morphogenesis. Inactivation of this system
is thought to be responsible for cancer invasion and metastasis. A human
hepatocellular carcinoma (HCC) cell line, KYN-2, was observed to have
great potential for intrahepatic metastasis when orthotopically implanted
into the liver of SCID mice. In vitro cultures of KYN-2 cells showed that
they formed trabecular structures in suspension but lost tight cell-cell
adhesion and became scattered when attached to a substratum such as collagen
or fibronectin. In response to adhesion to the substratum, subcellular
colocalization of E-cadherin and actin filaments were shown to be reduced,
and a significant amount of [alpha]-catenin was dissociated from the E-cadherin--catenin
complex in KYN-2 cells. These changes of cell-cell adhesion were blocked
by inhibitory monoclonal antibodies against [beta]1 and [beta]5 integrins.
We found that c-Src was coimmunoprecipitated with E-cadherin--catenin
complex and was tyrosine-dephosphorylated and activated in the adherent
cells. The tyrosine dephosphorylation of c-Src was induced by cell adhesion
to the substratum and inhibited by addition of inhibitory monoclonal antibodies
against [beta]1 and [beta]5 integrins. These findings indicate that integrin-mediated
cell-substratum adhesion inhibits cadherin-mediated cell-cell adhesion,
possibly through c-Src activation, and suggest that this cross-talk mediates
transient inactivation of the cadherin system and plays an important role
in intrahepatic metastasis of human HCC. Modulation of this interaction
might provide a new approach to prevent metastasis and recurrence of HCC.
(Lab Invest 2000, 80: 387-394)
|
| |
|
| |
 |